Serum leptin levels correlate with interleukin‐6 levels and disease activity in patients with ankylosing spondylitis

References

• Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J. M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425–32
   PubMed Web of Science ®Google Scholar
• Maffei M., Fei H., Lee G. H., Dani C., Leroy P., Zhang Y., et al. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 1995; 92: 6957–60
   PubMed Web of Science ®Google Scholar
• Maffei M., Halaas J., Ravussin E., Pratley R. E., Lee G. H., Zhang Y., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight‐reduced subjects. Nature Med 1995; 1: 1155–61
   PubMed Web of Science ®Google Scholar
• Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., et al. Serum immunoreactive‐leptin concentrations in normal‐weight and obese humans. N Engl J Med 1996; 334: 292–5
   PubMed Web of Science ®Google Scholar
• Friedman J. M., Halaas J. L. Leptin and the regulation of body weight in mammals. Nature 1998; 395: 763–70
   PubMed Web of Science ®Google Scholar
• La Cava A., Alviggi C., Matarese G. Unraveling the multiple roles of leptin in inflammation and autoimmunity. J Mol Med 2004; 82: 4–11
   PubMed Web of Science ®Google Scholar
• Sarraf P., Frederich R. C., Turner E. M., Ma G., Jaskowiak N. T., Rivet D. J 3rd., et al. Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med 1997; 185: 171–5
   PubMed Web of Science ®Google Scholar
• Loffreda S., Yang S. Q., Lin H. Z., Karp C. L., Brengman M. L., Wang D. J., et al. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57–65
   PubMed Web of Science ®Google Scholar
• Santos‐Alvarez J., Goberna R., Sanchez‐Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194: 6–11
   PubMed Web of Science ®Google Scholar
• Martin‐Romero C., Santos‐Alvarez J., Goberna R., Sanchez‐Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell Immunol 2000; 199: 15–24
   PubMed Web of Science ®Google Scholar
• Chen A. R., McKinnon K. P., Koren H. S. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D‐treated WEHI‐164 target cells via increased secretion of a monokine similar to tumor necrosis factor. J Immunol 1985; 135: 3978–87
   PubMed Web of Science ®Google Scholar
• Lord G. M., Matarese G., Howard J. K., Baker R. J., Bloom S. R., Lechler R. I. Leptin modulates the T‐cell immune response and reverses starvation‐induced immunosuppression. Nature 1998; 394: 897–901
   PubMed Web of Science ®Google Scholar
• Busso N., So A., Chobaz‐Peclat V., Morard C., Martinez‐Soria E., Talabot‐Ayer D., Gabay C. Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis. J Immunol 2002; 168: 875–82
   PubMed Web of Science ®Google Scholar
• Fraser D. A., Thoen J., Reseland J. E., Forre O., Kjeldsen‐Kragh J. Decreased CD4+ lymphocyte activation and increased interleukin‐4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 1999; 18: 394–401
   PubMed Web of Science ®Google Scholar
• Gabay C., Dreyer M., Pellegrinelli N., Chicheportiche R., Meier C. A. Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J Clin Endocrinol Metab 2001; 86: 783–91
   PubMed Web of Science ®Google Scholar
• Faggioni R., Fantuzzi G., Gabay C., Moser A., Dinarello C. A., Feingold K. R., et al. Leptin deficiency enhances sensitivity to endotoxin‐induced lethality. Am J Physiol 1999; 276: 136–42
   PubMed Web of Science ®Google Scholar
• Takahashi N., Waelput W., Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 1999; 189: 207–12
   PubMed Web of Science ®Google Scholar
• Braun J., Bollow M., Neure L., Seipelt E., Seyrekbasan F., Herbst H., et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 1995; 38: 499–505
   PubMed Web of Science ®Google Scholar
• Francois R. J., Braun J., Khan M. A. Entheses and enthesitis: a histopathologic review and relevance to spondyloarthritides. Curr Opin Rheumatol 2001; 13: 255–64
   PubMed Web of Science ®Google Scholar
• Gratacos J., Collado A., Filella X., Sanmarti R., Canete J., Llena J., et al. Serum cytokines (IL‐6, TNF‐alpha, IL‐1 beta and IFN‐gamma) in ankylosing spondylitis: a close correlation between serum IL‐6 and disease activity and severity. Br J Rheumatol 1994; 33: 927–31
   PubMedGoogle Scholar
• Duftner C., Dejaco C., Kullich W., Klauser A., Goldberger C., Falkenbach A., et al. Preferential type 1 chemokine receptors and cytokine production of CD28– T cells in ankylosing spondylitis. Ann Rheum Dis 2006; 65: 647–53
   PubMed Web of Science ®Google Scholar
• Braun J., Baraliakos X., Brandt J., Sieper J. Therapy of ankylosing spondylitis. Part II: Biological therapies in the spondyloarthritides. Scand J Rheumatol 2005; 34: 178–90
   PubMed Web of Science ®Google Scholar
• van der Linden S., Valkenburg H. A., Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–8
   PubMed Web of Science ®Google Scholar
• Braun J., Baraliakos X., Godolias G., Bohm H. Therapy of ankylosing spondylitis – a review. Part I: Conventional medical treatment and surgical therapy. Scand J Rheumatol 2005; 34: 97–108
   PubMed Web of Science ®Google Scholar
• Garrett S., Jenkinson T., Kennedy L. G., Whitelock H., Gaisford P., Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–91
   PubMed Web of Science ®Google Scholar
• Trujillo M. E., Sullivan S., Harten I., Schneider S. H., Greenberg A. S., Fried S. K. Interleukin‐6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 2004; 89: 5577–82
   PubMed Web of Science ®Google Scholar
• Tartaglia L. A., Dembski M., Weng X., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor. Cell 1995; 83: 1263–71
   PubMed Web of Science ®Google Scholar
• Baumann H., Morella K. K., White D. W., Dembski M., Bailon P. S., Kim H., et al. The full leptin receptor has signaling capabilities of interleukin 6‐type cytokine receptors. Proc Natl Acad Sci USA 1996; 93: 8374–8
   PubMed Web of Science ®Google Scholar
• Faggioni R., Feingold K. R., Grunfeld C. Leptin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J 2001; 14: 2565–71
   Web of Science ®Google Scholar
• Zarkesh‐Esfahani H., Pockley G., Metcalfe R. A., Bidlingmaier M., Wu Z., Ajami A., et al. High‐dose leptin activates human leukocytes via receptor expression on monocytes. J Immunol 2001; 167: 4593–9
   PubMed Web of Science ®Google Scholar